France· FR:64323500
OXACILLINE PANPHARMA 1 g, poudre pour solution injectable (IV)
A oxacillin product containing oxacilline sodique, registered in France by PANPHARMA. The same ATC class is registered in 5 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Oxacillin is registered in 5 of 19 countries.
Countries holding a registration under ATC J01CF04 (oxacillin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 5 of them publish a price we can compare per daily dose
Oxacillin · ATC J01CF04
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Polandprice
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OXACILLINE SODIQUE
- Manufacturer
- PANPHARMA
- Country
- France (FR)
- ATC code
- J01CF04
- ATC class
- Oxacillin
- Defined daily dose
- 2 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093479948825 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
59 interactions on record for oxacillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxacillin · interactions on record
59 records
- 3 severe
- 16 moderate
- 4 minor
- 36 info
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxacillin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesoxacillinOnesource Specialty Pharma Limited
- CzechiaOXACILIN AVMCAV Medical CZ s.r.o., Praha
- BelgiumPenstapho Injection 1 gBristol-Myers Squibb Belgium
- ItalyPENSTAPHO*1 fiala IM EV 1 g + 1 fiala solvLABORATOIRES DELBERT
- PolandOxacilin NoramedaNorameda UAB
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Czechia · Oxacilin Avmc, Prostaphlin
- Estonia · Oxacillin Auxilia
- Italy · Oxciva, Penstapho
- Latvia · Oxacillin Pan
- Poland · Oxacilin Norameda
- Romania · Oxacilina Arena, Oxacilina Atb
- Slovakia · Oxacilin Avmc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e30560f4-b6b6-4b32-ac63-033447574e3f GET /v1/drugs/e30560f4-b6b6-4b32-ac63-033447574e3f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64323500",
"date_amm": "1998-08-17",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "OXACILLINE SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about oxacillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.